Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease

Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease

IntroductionSarcopenia is present in many chronic disease states including decompensated end stage liver disease (ESLD) and non-cirrhotic non-alcoholic fatty liver disease (NAFLD). Sarcopenia in ESLD can negatively impact quality of life and increase mortality. Despite this, very little is understoo...

Full description

Bibliographic Details
Main Authors: Jonathan I. Quinlan, Amritpal Dhaliwal, Felicity Williams, Sophie L. Allen, Leigh Breen, Carolyn A. Greig, Janet M. Lord, Matthew J. Armstrong, Ahmed M. Elsharkawy
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Physiology
Subjects:
chronic liver disease (CLD)
muscle biopsy
non-alcoholic fatty liver (NAFLD)
end stage liver disease
liver disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.817152/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2021.817152/full

Similar Items